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Coa2 Is an Assembly Factor for Yeast Cytochrome c Oxidase
Biogenesis That Facilitates the Maturation of Cox1䌤
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The assembly of cytochrome c oxidase (CcO) in yeast mitochondria is dependent on a new assembly factor
designated Coa2. Coa2 was identified from its ability to suppress the respiratory deficiency of coa1⌬ and shy1⌬
cells. Coa1 and Shy1 function at an early step in maturation of the Cox1 subunit of CcO. Coa2 functions
downstream of the Mss51-Coa1 step in Cox1 maturation and likely concurrent with the Shy1-related heme
a3 insertion into Cox1. Coa2 interacts with Shy1. Cells lacking Coa2 show a rapid degradation of newly
synthesized Cox1. Rapid Cox1 proteolysis also occurs in shy1⌬ cells, suggesting that in the absence of
Coa2 or Shy1, Cox1 forms an unstable conformer. Overexpression of Cox10 or Cox5a and Cox6 or
attenuation of the proteolytic activity of the m-AAA protease partially restores respiration in coa2⌬ cells.
The matrix-localized Coa2 protein may aid in stabilizing an early Cox1 intermediate containing the
nuclear subunits Cox5a and Cox6.
the Cox2 subunit. Consistent with this postulate is the fact that
Cox2 associates downstream of the Cox1, Cox5a, and Cox6
complex (18).
In addition to translational initiation, Mss51 has a posttranslational function in yeast Cox1 maturation (8, 28). Mss51 and
Cox14 form a complex that interacts with Cox1 and regulates
Cox1 translation/elongation. In cells lacking the yeast gene
SURF1, i.e., shy1⌬ cells, Cox1 translation is stated to be attenuated (8). We recently reported that Coa1 functions in an early
step of Cox1 assembly in yeast (29). Coa1 is part of the Mss51,
Cox14, and Cox1 complex and, in addition, binds to Shy1 in a
separate complex (25, 29). Coa1 appears to coordinate the
transition of newly synthesized Cox1 from the Mss51 complex
to a later intermediate, involving Shy1, that likely functions in
heme a3 insertion. We isolated a series of extragenic suppressors of coa1⌬ cells (29). The high-copy-number genes MSS51
and COX10 suppress the respiratory defect of coa1⌬ cells. In
addition, we observed that respiration in both coa1⌬ and shy1⌬
cells is enhanced when MSS51 and COX10 are coexpressed.
Cox10 is a farnesyl transferase involved in the biosynthesis of
heme a. The synergistic suppression is consistent with Mss51
and Cox10 affecting Cox1 translation and heme a3 insertion,
suggesting that Coa1 links cotranslational insertion and heme
addition to Cox1.
A fourth extragenic suppressor of coa1⌬ cells was found.
High-copy expression of the unannotated yeast open reading
frame (ORF) YPL189C-A, designated Coa2 (cytochrome oxidase assembly 2), is shown here to effectively restore respiratory growth to coa1⌬ and shy1⌬ cells. We report that Coa2
functions in Cox1 maturation downstream from the Mss51
translational elongation step and at the heme a3 insertion step
involving Shy1.

Cytochrome c oxidase (CcO) is the terminal enzyme of the
energy-transducing respiratory chain in mitochondria. Eukaryotic CcO consists of 12 or 13 subunits, with three mitochondrially encoded subunits (Cox1 to Cox3) forming the core
enzyme embedded within the mitochondrial inner membrane
(IM). The remaining nucleus-encoded subunits pack on the
periphery of the catalytic core (35). The core enzyme contains
three copper atoms and two heme a cofactors (34).
The biogenesis of CcO, occurring within the IM, commences
with the mitochondrial synthesis of the Cox1 subunit, followed
by the insertion of heme a and copper cofactors and the addition of the remaining subunits. The translation of Cox1 on
mitoribosomes occurs in juxtaposition to the IM and is mediated in the yeast Saccharomyces cerevisiae by the IM-tethered
translational activator Pet309 along with the IM-associated
Mss51 protein (23, 24, 28, 30). The translational activators may
recruit mitoribosomes and promote cotranslational IM insertion together with the Oxa1 translocase (9, 17).
Insights have also been gleaned on the assembly process of
CcO through characterization of stalled intermediate complexes in human cells of patients with mutations in assembly
factors. One intermediate that accumulates in Leigh’s syndrome patients with SURF1 mutations consists of Cox1,
CoxIV, and CoxVa (32, 37, 40). This intermediate fails to
accumulate in patient cells with mutations in Cox10 and
Cox15, two enzymes that function in heme a biosynthesis.
Thus, the prediction is that heme a insertion occurs prior to the
addition of CoxIV and CoxVa (corresponding to yeast Cox5a/b
and Cox6) (1, 2). Two heme a moieties and a copper ion are
buried inside a barrel within Cox1 (34). These cofactors may be
inserted through an interface obstructed by the association of
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MATERIALS AND METHODS
Yeast strains and vectors. Yeast strains used in this study are described in
Table 1. The deletion strains were created by disruption, using homologous
recombination of KanMX4 or Candida albicans URA3. Proper integration was
confirmed by PCR of the locus, and reversion of the phenotype induced by the
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TABLE 1. Yeast strains used in this studya

Strain
BY4741
BY4741 ⌬coa2
W303
W303 ⌬coa2
W303 ⌬coa2 ⌬cox14
W303 ⌬coa2
W303 ⌬coa2 ⌬yta12
W303 ⌬coa2 ⌬coa1
W303 ⌬shy1
W303 ⌬shy1 ⌬coa2
W303 ⌬cox5a
cox1⌬::ARG8m
cox1⌬::ARG8m ⌬coa2
COX1(1-512)::ARG8
COX1(1-512)::ARG8 ⌬coa2
COX1(1-512)::ARG8 ⌬cox5a
DY5113
COA2-3HA
COA2-13Myc
COA2-13Myc ⌬pet309
MSS51-13Myc COA1-3HA
MSS51-13Myc COA1-3HA ⌬coa2
MSS51-13Myc COA1-3HA ⌬pet309
BY4743 ⌬shy1
BY4743 ⌬coa1
BY4743
BY4743 ⌬cox5a
BY4743 ⌬cox6
BY4743 ⌬cox7

Genotype
MATa his3⌬1 leu2⌬0 met15⌬0 ura3⌬0
MATa his3⌬1 leu2⌬0 met15⌬0 ura3⌬0 ⌬coa2::kanMX4
MAT␣ ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1
MAT␣ ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 ⌬coa2::kanMX4
MAT␣ ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 ⌬coa2::kanMX4 ⌬cox14::CaURA3
MAT␣ ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 ⌬coa2::CaURA3
MAT␣ ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 ⌬coa2::CaURA3 ⌬yta12::kanMX4
MAT␣ ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 ⌬coa2::CaURA3 ⌬coa1::kanMX4
MAT␣ ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 ⌬shy1::URA3
MAT␣ ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 ⌬shy1::URA3 ⌬coa2::kanMX4
MAT␣ ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 ⌬cox5a::HIS3
MATa lys2 leu2-3,112 arg8::hisG ura3-52 关cox1⌬::ARG8m兴
MATa lys2 leu2-3,112 arg8::hisG ura3-52 关cox1⌬::ARG8m兴 ⌬coa2::kanMX4
MATa lys2 leu2-3,112 arg8::hisG ura3-52 关COX1(1-512)::ARG8m兴
MATa lys2 leu2-3,112 arg8::hisG ura3-52 关COX1(1-512)::ARG8m兴 ⌬coa2::kanMX4
MATa lys2 leu2-3,112 arg8::hisG ura3-52 关COX1(1-512)::ARG8m兴 ⌬cox5a::kanMX4
MATa ade2-1 his3-1,15 leu2-3,112 trp1⌬ ura3-1
MATa ade2-1 his3-1,15 leu2-3,112 trp1⌬ ura3-1 COA2-3HA::TRP1
MATa ade2-1 his3-1,15 leu2-3,112 trp1⌬ ura3-1 COA2-13Myc::TRP1
MATa ade2-1 his3-1,15 leu2-3,112 trp1⌬ ura3-1 COA2-13Myc::TRP1 ⌬pet309::CaURA3
MATa ade2-1 his3-1,15 leu2-3,112 trp1⌬ ura3-1 COA1-3HA::TRP1 MSS51-13Myc::HIS3MX6
MATa ade2-1 his3-1,15 leu2-3,112 trp1⌬ ura3-1 COA1-3HA::TRP1 MSS51-13Myc::HIS3MX6
⌬coa2::kanMX4
MATa ade2-1 his3-1,15 leu2-3,112 trp1⌬ ura3-1 COA1-3HA::TRP1 MSS51-13Myc::HIS3MX6
⌬pet309::CaURA3
MATa/␣ his3⌬1/his3⌬1 leu2⌬0/leu2⌬0 LYS2/lys2⌬0 MET15/met15⌬0 ura3⌬0/ura3⌬0
⌬shy1::kanMX4
MATa/␣ his3⌬1/his3⌬1 leu2⌬0/leu2⌬0 LYS2/lys2⌬0 MET15/met15⌬0 ura3⌬0/ura3⌬0
⌬coa1::kanMX4
MATa/␣ his3⌬1/his3⌬1 leu2⌬0/leu2⌬0 LYS2/lys2⌬0 MET15/met15⌬0 ura3⌬0/ura3⌬0
MATa/␣ his3⌬1/his3⌬1 leu2⌬0/leu2⌬0 LYS2/lys2⌬0 MET15/met15⌬0 ura3⌬0/ura3⌬0
⌬cox5a::kanMX4
MATa/␣ his3⌬1/his3⌬1 leu2⌬0/leu2⌬0 LYS2/lys2⌬0 MET15/met15⌬0 ura3⌬0/ura3⌬0
⌬cox6::kanMX4
MATa/␣ hs3⌬1/his3⌬1 leu2⌬0/leu2⌬0 LYS2/lys2⌬0 MET15/met15⌬0 ura3⌬0/ura3⌬0
⌬cox7::kanMX4

Reference
or source
Invitrogen Corp.
This work
This
This
This
This
This
7
This
16
28
This
28
This
This
20
This
This
This
29
This

work
work
work
work
work
work
work
work
work
work
work
work
work

This work
Invitrogen Corp.
Invitrogen Corp.
Invitrogen Corp.
Invitrogen Corp.
Invitrogen Corp.
Invitrogen Corp.

a
The strains with the 3HA or 13Myc tag were generated in the DY5113 background by PCR-based gene modification, using the template pFA6a-3HA-TRP1,
pFA6a-13MYC-TRP1, pFA6a-3HA-HIS3MX6, or pFA6a-13MYC-HIS3MX6 (22).

deletion was ensured by complementation with a wild-type (WT) copy of the
gene on a plasmid. Cells were cultured in either rich medium or synthetic
complete (SC) medium lacking the appropriate nutrients for plasmid selection.
The carbon source used was either 2% glucose, 2% glycerol-2% lactate, or 2%
raffinose. COA2 was cloned into YEp lac181 with 400 bp of its own promoter and
terminator, using BamHI and SalI. The COA2 ORF was cloned into pRS416
under the control of the MET25 promoter and the CYC1 terminator (26), using
BamHI and SalI. COX5a and COX6 were inserted into pRS426 and pRS423
under the control of their own promoters (600 and 430 bp, respectively) and
terminators (500 bp) by restriction with BamHI and XhoI. The vector containing
Yta12(E614Q) was a gift from Thomas Langer. The COX10 ORF with the
coding sequence for a 3⬘ six-His peptide tag was cloned into pRS426 under the
control of the MET25 promoter and CYC1 terminator. The same promoter and
terminator set was used for cloning of the MSS51 ORF into pRS423. The SHY1
ORF with a 13-Myc 3⬘ tag was cloned into pRS416 under the control of its own
promoter and the ADH1 terminator. Sequencing was used to confirm cloning
products in all created vectors. Yeast strains were transformed using lithium
acetate.
Mitochondrial purification and assays. Intact mitochondria were isolated
from yeast as described previously (13, 14). The total mitochondrial protein
concentration was determined by Bradford assay (11). Cytochrome c oxidase
activity was assessed by monitoring the oxidation of reduced cytochrome c, and
reaction rates were normalized to total mitochondrial protein (12). The oxygen
consumption of cells grown to stationary phase was determined on a model
5300A biological oxygen monitor (Yellow Springs Instrument Co.). The linear response was considered in calculating the rate of oxygen consumption.
Heme analysis was conducted on purified mitochondria (1 to 2 mg of protein)
extracted with 0.5 ml of acetone containing 2.5% HCl, as described previously
(29). The pH of the extract was adjusted to 4 by addition of 1 l formic acid
and titration with KOH. The sample was clarified by centrifugation at 13,000
rpm for 5 min, and 1 ml was injected onto a 3.9- by 300-mm Bondclone C18
column (Phenomex).

Hydrogen peroxide sensitivity, respiratory growth assay, and arginine auxotrophy. Sensitivities of the strains and transformants to hydrogen peroxide were
assessed as previously described (21). To test respiratory competence, the strains
were grown overnight in selective medium containing 2% raffinose-0.2% glucose,
serially diluted, and spotted on 2% glucose-containing medium (control) and 2%
glycerol-2% lactate-containing rich (YPLG) or SC (SCLG) medium. The cox1⌬::
ARG8 COX1(1-512)::ARG8 strains and their derivatives were grown overnight in
selective medium containing 2% glucose and 1⫻ arginine (20 mg/liter Arg) or
0.2⫻ Arg, as indicated. The cultures were serially diluted and dropped onto SC
medium with 2% glucose containing no Arg or 1⫻ Arg (control).
In vivo mitochondrial protein translation assay. The cells were grown overnight in selective medium containing 2% raffinose and then reinoculated in
YP-2% raffinose to grow to an absorbance of 1 at 600 nm. The labeling and
preparation of the samples for 12% sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) or 15% SDS-PAGE (to visualize mp15) were done
as described previously (7). The gel was dried, and radiolabeled proteins were
visualized by exposing autoradiographic films at ⫺80°C.
BN-PAGE. Blue native PAGE (BN-PAGE) analysis was performed essentially
as described previously (38), except that 1.5% digitonin was used. After incubation for 15 min on ice and centrifugation (20,000 ⫻ g for 10 min at 2°C),
supernatants were mixed with sample buffer (5% Coomassie brilliant blue G250,
0.5 M 6-aminocaproic acid, pH 7.0) and loaded on a gradient polyacrylamide gel.
Separated complexes were detected by immunoblotting on a polyvinylidene
difluoride membrane.
Immunoassays. Protein samples were separated in 15% acrylamide gels and
transferred to nitrocellulose. Proteins were visualized using enhanced chemiluminescence (ECL) reagents with horseradish peroxidase-conjugated secondary
antibodies. Anti-Myc and antihemagglutinin (anti-HA) antisera were purchased
from Santa Cruz, antiporin was purchased from Molecular Probes, and antisera
to Cox1 to Cox3 were purchased from Mitosciences. Antiserum to Sod2 was
provided by Val Culotta, and antisera to Cyb2 and Cyc1 were provided by Carla
Koehler. Alex Tzagoloff provided antiserum to F1 ATP synthase, and Peter
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FIG. 1. Overexpression of COA2 suppresses the respiratory growth defect of coa1⌬ and shy1⌬ cells and is synergistic with MSS51. (A) coa1⌬
cells (BY4743 background) transformed with episomal vectors expressing MSS51, MDJ1, COX10, or COA2 were grown in SC-2% raffinose, serially
diluted, and spotted on SCLG or 2% glucose. The plates were incubated at 30°C for 2 days (glucose) or 7 days (SCLG). (B) shy1⌬ cells (W303
background) transformed with an episomal vector expressing COA2 or an empty vector were grown as described for panel A and spotted on YPLG
or 2% glucose. The plates were incubated at 30°C for 2 days (glucose) or 4 days (YPLG). (C) BY4743 coa1⌬ cells transformed with episomal
vectors expressing MSS51, COA2, or both were grown in SC-2% raffinose, serially diluted, and spotted on SCLG or 2% glucose. The plates were
incubated at 30°C for 2 days (glucose) or 6 days (SCLG). (D) BY4743 shy1⌬ cells transformed with the same vectors as those described for panel
C were grown in SC-2% raffinose, serially diluted, and spotted on SCLG, 2% glucose, or YPLG. The plates were incubated at 30°C for 2 days
(glucose) or 6 days.

Rehling provided antiserum to Cyt1. For immunoprecipitation (IP), purified
mitochondria (0.3 mg protein) were solubilized by incubation in 0.5 ml 40 mM
potassium phosphate, 200 mM ammonium sulfate, 1 mM phenylmethylsulfonyl
fluoride, and 1% digitonin (IP buffer) for 10 min at 4°C. Lysates were centrifuged
at 16,000 ⫻ g for 30 min at 4°C. IP was performed by incubating the clarified
lysates overnight at 4°C with 30 l anti-HA–agarose conjugate (Santa Cruz
Biotechnology). The beads were pelleted by centrifugation at 1,000 ⫻ g for 1 min
and washed with 0.5 ml of IP buffer for 5 min, and this was repeated four times.
The agarose beads were eluted by boiling for 5 min in 50 l SDS-PAGE loading
buffer. The clarified lysate, final wash, and elution fractions were analyzed by
immunoblotting.

RESULTS
Coa2 is a multicopy suppressor of coa1⌬ and shy1⌬ cell
respiratory growth defect. In a search for high-copy-number
suppressors of the respiratory growth defect of coa1⌬ cells, we
recovered MSS51, COX10, and MDJ1 (29). A fourth suppressor, which we designated COA2, was also identified (Fig. 1A).
Five plasmids recovered from respiration-competent clones
contained a DNA fragment encompassing YPL189c-a, an uncharacterized ORF that was identified by homology to an ORF
in Ashbya gossypii (10, 19). Our identification of this gene as an

extragenic suppressor and the respiratory deficiency of the
deletion of YPL189c-a (10, 19) imply that YPL189c-a is a
functional gene. The complementation of the respiratory
growth defect of coa1⌬ cells by overexpression of COA2 is
similar to that observed by overexpression of MSS51 (Fig. 1A).
Since Coa1 and Shy1 function at a related step in CcO assembly (29), we tested whether COA2 overexpression rescued the
respiratory defect of shy1⌬ cells. Coa2 overexpression was able
to partially complement the respiratory growth defect of shy1⌬
cells (Fig. 1B). A synergistic effect of MSS51 and COA2 on the
suppression of the respiratory defect of coa1⌬ and shy1⌬
strains was found (Fig. 1C and D), consistent with Mss51 and
Coa2 affecting distinct aspects of CcO maturation. This is analogous to the synergistic suppression effects we reported previously for MSS51 and COX10 in coa1⌬ and shy1⌬ strains (29).
coa2⌬ cells are respiration deficient, with a CcO-specific
defect. The COA2 ORF was deleted by homologous recombination with a KanMX4 cassette in BY4741 and W303 strain
backgrounds. The coa2⌬ strains showed normal growth on
glucose medium but were unable to propagate on respiratory
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FIG. 2. coa2⌬ cells are respiration deficient. (A) coa2⌬ cells, isogenic WT cells, and coa2⌬ cells transformed with a centromeric vector
expressing the COA2 ORF under the control of the MET25 promoter
and the CYC1 terminator were grown in SC-2% glucose, serially diluted, and spotted on yeast extract-peptone-dextrose (YPD) or SCLG.
The plates were incubated at 30°C for 2 days (YPD) or 4 days (SCLG).
(B) coa2⌬ cells and the WT were grown in liquid YPD at 30°C, and
oxygen consumption (% O2/s/optical density value at 600 nm [OD600])
was measured. The data represent the averages for four independent
experiments, and the error bars indicate the standard errors.

medium containing glycerol and lactate as carbon sources (Fig.
2A). Introduction of a centromeric plasmid expressing COA2
under the control of the MET25 promoter and CYC1 terminator in the coa2⌬ strains restored respiratory growth to the WT
level. Consistent with the growth defect observed on glycerollactate medium, oxygen consumption was strongly reduced in
the coa2⌬ strains, compared to that in the isogenic WT strains
(Fig. 2B). Overall, these results confirm that Coa2 is necessary
for respiration in S. cerevisiae, as reported recently in a highthroughput study (19).
Since Coa1 and Shy1 are part of the CcO assembly machinery, we assessed whether the absence of COA2 led to a CcO
defect. CcO activity measured on purified mitochondria was
diminished to about 10% of the WT level in the coa2⌬ strains
(Fig. 3A), whereas bc1 activity (complex III) was reduced to 50
to 60% of the WT level (data not shown). Heme a, a cofactor
exclusive to CcO, was undetectable in mitochondrial extracts
of coa2⌬ strains, and heme b levels in mitochondria were 58%
of the WT level, consistent with the partial reduction in bc1
activity (Fig. 3B). Numerous CcO assembly mutants have reduced bc1 activity arising from partial pleiotropy (36). Immunoblotting showed an absence of Cox1 to Cox3 in mitochondria purified from the coa2⌬ strain. Despite the reduced bc1
activity, cytochrome c and Qcr7, a subunit of complex III, were
present at WT levels (Fig. 3C). CcO was undetectable in the
coa2⌬ mitochondria by BN-PAGE, whereas the CcO supercomplexes were evident in WT mitochondria (Fig. 3D). The
absence of CcO in coa2⌬ cells caused complex III to be redistributed from the III2-IV2 and III2-IV supercomplexes seen in
WT cells into the dimeric form (III2) (Fig. 3D). The deletion of
COA2 had no effect on complex V (Fig. 3D). Overall, these
data argue for a specific CcO defect in coa2⌬ cells.

MOL. CELL. BIOL.

Coa2 is a mitochondrial matrix soluble protein partially
associated with the IM. We chromosomally integrated three
copies of the HA epitope at the 3⬘ end of the COA2 ORF. The
tag did not affect the function of Coa2, as judged by the WT
growth on respiratory medium of the COA2-3HA strain (data
not shown). Nycodenz gradient-purified mitochondria isolated
from the COA2-3HA strain showed a single band at ⬃17 kDa
upon immunodetection with HA antiserum (Fig. 4A). This
apparent mass is higher than the expected 10.8 kDa, although
the basic isoelectric point of Coa2 (10.6) may account for its
aberrant migration in SDS-PAGE gels. Coa2 was detected
predominantly in the soluble fraction of sonicated mitochondria, like the soluble proteins Cyc1 and Sod2 (Fig. 4B). When
the concentration of sodium chloride in the sonication buffer
was increased, Cyc1 lost its membrane association, as expected,
whereas the fraction of Coa2 recovered in the pellet increased
(Fig. 4B). This salt effect suggests that Coa2 may have a hydrophobic interaction with a mitochondrial membrane or with
one of its proteins. This candidate interaction may involve a
hydrophobic segment between residues 13 and 33. In order to
determine the subcompartmentalization of Coa2, we treated
intact or hypotonically lysed mitochondria with proteinase K.
The intermembrane space (IMS) protein Cyc1 was degraded in
mitoplasts, whereas Coa2 was protected, similar to the matrix
protein Sod2 (Fig. 4C). Coa2, like Sod2, was retained in the
insoluble fraction of mitoplasts, whereas it was liberated in the
soluble fraction upon sonication of mitochondria (Fig. 4D). In
contrast, Ccs1, an IMS soluble protein, was mostly present in
the soluble fraction of mitoplasts. Coa2 was susceptible to
proteinase K degradation upon sonication of mitochondria
(Fig. 4E) or solubilization of mitochondria with Triton X-100
(data not shown). Taken together, these results show that Coa2
is a soluble protein in the mitochondrial matrix and that Coa2
may have an interaction with an IM-anchored protein or the
IM itself.
The absence of COA2 leads to a low level of newly synthesized Cox1. In vivo labeling of mitochondrial translation products revealed that very limited amounts of Cox1 were detected
in coa2⌬ cells in both W303 and BY4741 backgrounds (Fig.
5A). Cox2, Cox3, and Var1 were translated at WT levels, while
Cob (cytochrome b) translation was slightly increased (Fig. 5A;
data not shown). During the 60-min chase, the levels of Var1
and cytochrome b remained stable, whereas Cox2 and Cox3
levels diminished markedly in coa2⌬ cells, a phenomenon consistent with a CcO assembly defect. A low abundance of Cox1
during the pulse phase of in vivo mitochondrial translation
experiments has been reported for most CcO mutants (8). This
has been proposed to result from the accumulation of an
Mss51-Cox14-Cox1 complex which titrates Mss51 out of its
Cox1 translational activator role (8). The synthesis of Cox1 can
be restored in certain CcO mutants when Mss51 is overexpressed, when COX14 is deleted (8), or when COA1 is deleted
(29). Deletion of COX14 or COA1 in coa2⌬ cells restored WT
levels of newly synthesized Cox1, whereas overexpression of
Mss51 only partially returned the Cox1 level (Fig. 5B). However, none of these strains recovered respiratory growth (see
Fig. 9A; data not shown).
Recently, Barrientos and coworkers showed that attenuation
of Mss51 levels or titration of Mss51 out of its Cox1 translational activator role leads to the synthesis of mp15, a truncated
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FIG. 3. Deletion of COA2 results in a CcO-specific defect. (A) coa2⌬ cells and the isogenic WT were grown in YP-2% raffinose, and
mitochondria were purified and assayed for CcO activity (⌬OD550/min/10 g protein). The data represent the averages for three independent
experiments, and the error bars indicate the standard errors. (B) Heme was extracted from mitochondria (2 mg protein) purified from coa2⌬ or
W303 cells and separated by reverse-phase high-performance liquid chromatography. The peaks corresponding to heme b (B), heme a (A), and
protoporphyrin (P) are shown. (C) Immunoblot of mitochondria (30 g protein) from coa2⌬ cells or from WT W303 cells. (D) Mitochondria (200
g protein) isolated from either the WT or coa2⌬ strain were solubilized in buffer containing 1.5% digitonin. Lysates were loaded onto a
continuous 4 to 13% gradient gel, and protein complexes were separated by BN-PAGE. The distribution of respiratory complexes was analyzed
by immunoblotting with antisera against Cyt1, Cox2, and the F1 subunit.

translation product of COX1 mRNA, in the W303 background
(39). mp15 was apparent in cox5a⌬ cells, but its abundance was
lower in coa2⌬ cells (Fig. 5C). Consistent with reported data
(39), mp15 synthesis was abrogated when cox5a⌬ or coa2⌬
cells were treated with low levels of chloramphenicol prior to
being labeled, and the synthesis of some Cox1 was restored
(Fig. 5C). The low abundance of mp15 in coa2⌬ cells suggests
that Mss51 is still able to fulfill its translation functions in the
absence of COA2.
Cox1 is translated but rapidly degraded in coa2⌬ cells. To
evaluate the status of translation at the COX1 locus in coa2⌬
cells, we used Arg8 reporter strains constructed by Fox and
coworkers (28). Arg8 is encoded by a nuclear gene and is
imported to the mitochondrial matrix, where it participates in
the biosynthesis of arginine. These reporter strains, constructed in an arg8⌬ background, contain the ARG8 gene in
place of the COX1 ORF (cox1⌬::ARG8) or fused at the 3⬘ end

of the 512-codon intronless form of the COX1 coding sequence
[COX1(1-512)::ARG8] (28). The growth of the fusion strains in
medium lacking arginine is indicative of translation of
COX1(1-512)::ARG8 mRNA. Deletion of COA2 in these two
strains did not produce an arginine auxotrophy, implying that
translation was occurring at the COX1 locus (Fig. 6A). As
expected, the COX1(1-512)::ARG8 strain was unable to respire
when COA2 was deleted (Fig. 6A). To ascertain that the arginine prototrophy of the cox1⌬::ARG8 and COX1(1-512)::
ARG8 strains lacking COA2 was not sustained only by small
amounts of Arg8, we performed in vivo mitochondrial translation assays with these strains. The levels of mature Arg8
detected in the cox1⌬::ARG8 strain were comparable whether
COA2 was present or not (Fig. 6B). For the COX1(1-512)::
ARG8 strain, a band corresponding to the unprocessed fusion
was detected during the pulse phase of the reaction (Fig. 6C).
The unprocessed fusion band, although clearly detectable, was
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FIG. 4. Coa2 is a soluble matrix protein loosely associated with the IM. (A) Immunoblot of mitochondria (mito) and the postmitochondrial
fraction (PMF) purified from the COA2-3HA strain. Pgk1 is a cytosolic marker, and Por1 is a mitochondrial outer membrane protein. (B) Purified
mitochondria from the COA2-3HA strain were sonicated in 20 mM HEPES, pH 7.4, and the indicated concentration of NaCl. The soluble and
insoluble fractions were separated by centrifugation at 100,000 ⫻ g for 1 h and analyzed by immunoblotting. Cyt1 is an integral IM protein, Cyc1
is associated with the IM, and Sod2 is a matrix soluble protein. (C) Purified mitochondria from the COA2-3HA strain were incubated in 20 mM
HEPES, pH 7.4, with 1.2 M sorbitol (intact) or without it (hypotonic), for 30 min on ice, digested on ice for 40 min with the indicated concentration
of proteinase K (PK) (g/ml), and analyzed by immunoblotting. (D) Purified mitochondria from the COA2-3HA strain were sonicated or incubated
in 20 mM HEPES, pH 7.4, with 1.2 M sorbitol (intact) or without it (hypotonic), for 30 min on ice. The soluble (S) and insoluble (P) fractions were
separated by centrifugation at 15,000 ⫻ g for 20 min and analyzed by immunoblotting. Ccs1 is a soluble IMS protein. (E) Purified mitochondria
as described in panel C were either sonicated (⫹) three times with 30-s pulses to rupture them or left intact (⫺). The samples were then treated
with 100 g/ml proteinase K (PK) at 24°C. At each time point (5, 10, and 20 min), 10 g of total protein was removed for immunoblotting.

reduced in the absence of COA2, as was its processing into
mature Cox1 during the chase. The experiments with the Arg8
reporter strains show that efficient translation occurs at the
COX1 locus even when the COA2 gene is deleted.
We previously reported that Mss51 is distributed into two
complexes upon BN-PAGE on a 4 to 13% gradient gel (29).
The largest complex (complex A) has been postulated to contain Cox14, Coa1, and newly synthesized Cox1, based on the
observation that this complex is disrupted upon deletion of
COX14 and is stabilized in shy1⌬ cells (29). Complex A was
resolved into two different complexes, A1 and A2, in a 5 to
13% gradient gel (Fig. 7A). In the absence of Coa2, Mss51
reproducibly formed the A2 complex, but the A1 complex was
attenuated (Fig. 7A). Neither the A1 nor A2 Mss51 complex
was present in pet309⌬ cells lacking the Cox1 translational
activator (Fig. 7A). Both A1 and A2 Mss51 complexes were

also abrogated in cells treated with chloramphenicol at a concentration that completely blocks mitochondrial translation
(Fig. 7B). These results suggest either that Cox1 is present in
the A1 and A2 complexes or that Cox1 synthesis induces formation of the two Mss51 complexes. The steady-state level of
Mss51 was unaffected by chloramphenicol treatment (data not
shown). The clear presence of the A2 Mss51 complex in coa2⌬
cells is consistent with Cox1 translation occurring in these cells.
The m-AAA protease, composed of Yta10-Yta12, is known
to degrade nonassembled mitochondrially encoded proteins
within the IM (4). Additionally, the m-AAA protease is essential for mitoribosome assembly through processing of MrpL32
(33). To evaluate whether the m-AAA protease was responsible for the low level of newly synthesized Cox1 in coa2⌬ cells,
we used a mutant m-AAA containing an E614Q substitution in
Yta12 that attenuates its proteolytic activity yet maintains its
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FIG. 5. The absence of COA2 leads to a low level of newly synthesized Cox1. (A) In vivo labeling of mitochondrial translation products.
coa2⌬ and WT cells were pulsed for 5 and 15 min with [35S]methionine.
After 15 min, 20 mM cold methionine (Met) was added, and the
reaction was chased for 20 and 60 min at 30°C. The samples were run
by 12% SDS-PAGE, and the gel was dried and exposed to autoradiographic film. (B) Cells were labeled for 8 and 20 min with [35S]Met at
30°C. The samples were analyzed as described for panel A. (C) W303
coa2⌬ or cox5a⌬ cells were treated (⫹) or not (⫺) for 3 h with 2 mg/ml
chloramphenicol (CAP) and then pulsed for 20 min with [35S]Met. The
samples were run by 15% SDS-PAGE, and the gel was dried and
exposed to autoradiographic film.

processing function (3, 33). Respiratory growth was partially
restored in coa2⌬ cells when YTA12 was deleted and replaced
with the Yta12 E614Q allele (Fig. 6D). Therefore, rapid degradation of Cox1 contributes to the CcO deficiency in coa2⌬
cells.
Coa2 acts near the Shy1 step in the CcO assembly pathway.
The absence of Coa2 had a dramatic effect on Shy1 complexes
visualized by BN-PAGE (Fig. 7C). The Shy1 complexes were
attenuated in coa2⌬ cells, and a lower-molecular-mass complex was observed. The reduced Shy1 complex level may arise
from diminished Cox1 levels, since the Shy1 complexes were
reported to contain Cox1 (25). The appearance of an altered
mass of Shy1 may be consistent with a physical complex between Shy1 and Coa2. To test whether Coa2 binds Shy1, we
carried out immunoprecipitation studies with cells containing
chromosomally tagged Coa2-3HA and Shy1-13Myc. Immunoprecipitation of Coa2 reproducibly resulted in coprecipitation
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of limited amounts of Shy1 (Fig. 7E). Genomically tagged
Coa2 migrated in BN-PAGE gels as a single complex whose
mass was approximately 100 kDa (Fig. 7D). This is in contrast
to the predicted mass of 27 kDa for Coa2-13Myc. The observed Coa2 complex is smaller than any of the Shy1-containing complexes (25), suggesting that Coa2 may not form a complex with Shy1 that can be visualized by BN-PAGE.
Shy1 is postulated to function in the heme a3 insertion step.
Rhodobacter cells lacking Shy1 are compromised in heme a3
insertion (31). Deletion of certain CcO assembly factors, such
as Cox11 and Sco1, renders yeast cells sensitive to hydrogen
peroxide (6), a phenotype generated by a pro-oxidant heme
a3-containing Cox1 assembly intermediate (21). Cells lacking
Shy1 are peroxide resistant (21). We found that coa2⌬ cells are
sensitive to hydrogen peroxide in a Cox1-dependent way, as
the cox1⌬::ARG8 strain did not exhibit sensitivity in the absence of COA2 (Fig. 8A). Thus, despite low levels of Cox1
observed in the 35S translation assay in coa2⌬ cells, sufficient
Cox1 was present to cause peroxide sensitivity. This highlights
the sensitivity of the hydrogen peroxide assay. As expected,
deletion of SHY1 in coa2⌬ cells abrogated the peroxide sensitivity (Fig. 8B). The peroxide sensitivity of coa2⌬ cells was also
suppressed by the deletion of either COA1 or COX14 (Fig.
8B), despite the elevated levels of newly synthesized Cox1
detected in coa2⌬ coa1⌬ and coa2⌬ cox14⌬ cells (Fig. 5B).
These results suggest that heme a3 insertion is precluded in the
absence of COA1 or COX14 and that COA2 acts downstream
of these two assembly factors. The interaction between Shy1
and Coa2, the perturbation of the Shy1 complexes in the absence of COA2, and the partial suppression of the respiratory
defect of shy1⌬ cells by overexpression of COA2 suggest a role
for Coa2 in the Shy1-mediated step of CcO maturation.
Coa2 has a stabilizing role with Cox1. The peroxide sensitivity of coa2⌬ cells suggests that limited quantities of heme
a3-Cox1 persist, but Cox1 is highly unstable in these cells. Since
the absence of COA2 leads to rapid degradation of newly
synthesized Cox1, we hypothesized that Coa2 may participate
in stabilizing Cox1. Overexpression of COA2 enhanced the
hydrogen peroxide sensitivity of cox11⌬ cells (Fig. 8C). This
may have arisen from a stabilization of the heme a3-Cox1
pro-oxidant intermediate. As expected, the H2O2 sensitivity of
cox11⌬ cells is dependent on Shy1, since cox11⌬ shy1⌬ cells
were resistant (Fig. 8D).
Cox10 is a farnesyl transferase converting heme b to heme o
in the heme a biosynthetic pathway. The high-copy-number
COX10 gene is a weak suppressor of the respiratory deficiency
of coa1⌬ cells and enhances the respiration of shy1⌬ cells
overexpressing Mss51. Cox10 is also partially effective in restoring respiratory growth of coa2⌬ cells (Fig. 9A). As expected from the observed respiratory growth, the COX10
transformants showed elevated levels of newly synthesized
Cox1 in a mitochondrial translation assay (Fig. 9B). This result
further supports the hypothesis that the CcO assembly defect
in coa2⌬ cells is posttranslational. Like the case for Coa2,
Cox10 overexpression exacerbates the peroxide sensitivity of
cox11⌬ cells (Fig. 8C). Therefore, Cox10 and Coa2 probably
participate in stabilizing Cox1 at a stage of assembly downstream of heme a3 insertion.
Cox1 occupies a central position in the mature CcO structure (35). We reasoned that the rapid degradation of Cox1 in
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FIG. 6. Cox1 is translated in the absence of COA2. (A) COA2 was deleted in arg8⌬ strains in which ARG8 replaces the COX1 codons (cox1⌬::
ARG8) or ARG8 is fused to 512 codons of COX1 [COX1(1-512)::ARG8]. The strains were grown in SC-2% glucose containing 0.2⫻ Arg (4
mg/liter), serially diluted, and spotted on YPD, SC-2% glucose with or without 1⫻ Arg, and YPLG. The plates were incubated at 30°C for 2 days
(glucose plates) or 4 days (YPLG). The arg4⌬ strain is shown as a control. (B) In vivo labeling of mitochondrial translation products of the cox1⌬::
ARG8 strain, with or without the COA2 gene. The cells were treated as described in the legend to Fig. 5A. The additional band is the mature Arg8
protein. WT corresponds to the W303 strain labeled for 20 min. (C) The COX1(1-512)::ARG8 strain, with or without the COA2 gene, was
radiolabeled as described in the legend to Fig. 5A. The bands corresponding to the Cox1::Arg8 fusion and to the mature Arg8 protein are marked.
WT corresponds to the W303 strain labeled for 20 min. (D) coa2⌬ yta12⌬ cells transformed with a centromeric vector expressing Yta12(E614Q)
were grown in SC-2% raffinose, serially diluted, and spotted on YPLG or YPD. The plates were incubated at 30°C for 2 days (YPD) or 6 days
(YPLG).

coa2⌬ cells likely occurs at an early stage in CcO assembly. In
humans, CoxIV and CoxVa (homologous to yeast Cox5a and
Cox6, respectively) associate with Cox1 as the first subassembly
intermediate (27, 37), and these subunits are in close contact
with Cox1 in bovine CcO. We addressed whether Cox5a and
Cox6 have a significant effect on Cox1 stability at early stages
of CcO assembly. We performed in vivo mitochondrial translation experiments with strains carrying deletions of different
CcO subunits, early assembled subunits, such as Cox5a and
Cox6, and subunits assembled at a later stage, such as Cox7
and Cox12. Only minimal levels of Cox1 were detected in
cox5a⌬ and cox6⌬ cells, whereas cox7⌬ and cox12⌬ cells
showed WT levels of Cox1 during the pulse phase of the
reaction (Fig. 9C). This result prompted us to overexpress
Cox5a and Cox6 in coa2⌬ cells. The two genes, overexpressed
individually, showed suppression of the coa2⌬ respiratory defect at 37°C (Fig. 9D). However, Cox5a and Cox6 had to be
overexpressed together to produce significant growth of coa2⌬
cells at 30°C (Fig. 9D). Coa2 is probably not required for
Cox5a stability per se, since the same residual level of Cox5a
was detected in coa2⌬ cells or in other CcO-deficient strains,
e.g., cox19⌬ cells (Fig. 9E). Coa2 may therefore aid in complex
formation between Cox5a and newly synthesized Cox1. How-

ever, no interactions were detected between Coa2 and Cox5a
by co-IP.
COA2 and MSS51 have nonredundant complementary functions. As in coa2⌬ cells, Cox1 synthesis is also unusually low in
cox5a⌬ cells. In order to test whether the low level of Cox1
detected in cox5a⌬ cells (Fig. 9C) was a result of a lack of
translation or rapid degradation, we disrupted COX5a in the
COX1(1-512)::ARG8 strain. This strain showed partial arginine auxotrophy, which was reversed by overexpression of
MSS51 or COA2 (Fig. 10A). Consistent with the Cox1 translation block model (8), overexpression of MSS51 in a cox5a⌬
strain partially returned the level of newly synthesized Cox1,
while COA2 overexpression did not (Fig. 10B). These results
suggest that MSS51 probably increases translation of the
Cox1-Arg8 fusion to rescue the arginine auxotrophy of the
COX1(1-512)::ARG8 cox5a⌬ strain, whereas COA2 suppression may arise in a posttranslational step through stabilization
of translated Cox1-Arg8. The low intensity of this band by in
vivo mitochondrial translation assay of the COX1(1-512)::
ARG8 cox5a⌬ strain prevented us from directly testing this
hypothesis.
We subsequently assayed the peroxide sensitivity of the
cox5a⌬ strain to assess heme a3-Cox1 levels. Cells lacking
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Cox5a were not sensitive unless MSS51 or COA2 was overexpressed (Fig. 10C). The coexpression of the two proteins further increased the peroxide sensitivity, arguing for nonredundant functions of MSS51 and COA2. High levels of Mss51 and
Coa2 appeared to enhance Cox1 levels, via translational and
posttranslational effects, respectively.
DISCUSSION
Coa2 is a 68-residue mitochondrial protein shown to be
required for respiration and to have a specific role in CcO
assembly in stabilizing Cox1 concurrent with the Shy1-dependent step of heme a3 insertion. The most striking aspect of the
CcO deficiency of coa2⌬ cells is a rapid degradation of newly
synthesized Cox1. Only a limited quantity of newly synthesized
Cox1 is observed with in vivo mitochondrial translation, and
this limitation results from rapid degradation rather than impaired synthesis. Multiple observations support this conclusion. First, deletion of COA2 in a COX1(1-512)::ARG8 fusion
strain resulted in normal growth on medium lacking arginine,
whereas deletion of COX5a induced Arg auxotrophy, partially
due to restricted translation. cox5a⌬ cells and coa2⌬ cells have
equally low levels of Cox1 in the W303 background. Second,
the A2 Mss51 complex persists in coa2⌬ cells, and this complex
is dependent on Cox1 translation. Thus, Cox1 translation is
unimpaired in coa2⌬ cells. Third, respiration was partially
recovered in coa2⌬ cells by diminishing the activity of the
m-AAA protease, a complex which has been shown to degrade
misfolded IM proteins (5). Fourth, the respiratory defect of
coa2⌬ cells is partially suppressed by Cox10, a protein that
functions at a posttranslational step in Cox1 maturation.
COX1 translation is impaired in many CcO assembly mutants due to the titration of Mss51 into a posttranslational
complex, preventing its function as a translational activator of
COX1 (8). This COX1 translation block is unlikely or at least
limited in coa2⌬ cells, since Arg8 is translated essentially normally in COX1(1-512)::ARG8 coa2⌬ cells. The attenuation of
Mss51 as a translational activator is also known to result in
synthesis of a truncated Cox1 translation product called mp15
(39). Whereas mp15 synthesis occurs in cox5a⌬ cells, only
limited quantities of mp15 are detected in coa2⌬ cells.
The translation block occurring in most CcO mutants can be
obviated by depleting Coa1 or Cox14. The deletion of COX14

FIG. 7. BN-PAGE analyses of protein complexes. (A) Mitochondria (200 g protein) isolated from either the WT, coa2⌬, or pet309⌬
strain containing a genomically tagged 13-Myc MSS51 gene (Mss51Myc) were solubilized in buffer containing 1.5% digitonin. Lysates
were loaded onto a continuous 5 to 13% gradient gel, and protein
complexes were separated by BN-PAGE. The distribution of Mss51
complexes was analyzed by immunoblotting with anti-Myc antibody.
(B) WT cells expressing endogenously tagged MSS51 were grown to
mid-logarithmic phase and incubated for an additional 3 h in the
presence (⫹) or absence (⫺) of chloramphenicol (CAP; 8 mg/ml).
Isolated mitochondria were lysed, subjected to BN-PAGE, and ana-

lyzed as described above. (C) Mitochondria were isolated from the WT
or coa2⌬ strain containing chromosomally tagged SHY1 (Shy1-Myc)
and were analyzed by both native (BN) and denaturing (SDS) PAGE,
using anti-Myc antibodies. Anti-F1 antiserum was used to visualize the
monomeric (V1) form of complex V, which served as a loading control
for BN-PAGE. (D) Mitochondria isolated from either the WT or a
strain containing a genomically tagged 13-Myc COA2 gene (Coa2Myc) were solubilized in buffer containing 1.5% digitonin. Lysates
were separated by BN-PAGE (6 to 16% gradient gel). (E) Coa2
interacts with Shy1. Mitochondria from COA2-3HA cells, COA2-3HA
cells expressing episomal SHY1-13Myc, or SHY1-13Myc cells were
solubilized in IP buffer, and clarified extracts were immunoprecipitated
with goat polyclonal anti-HA beads. Load, 1% of the soluble extract;
wash, 50% of the last wash concentrated by trichloroacetic acid precipitation; and elution, entire fraction of the bead eluate. All samples
were analyzed by immunoblotting as indicated.
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FIG. 8. Coa2 acts downstream of Coa1 and Shy1 in the assembly pathway of CcO. (A) Cells were grown to mid-exponential phase and
incubated with (⫹) or without (⫺) the indicated concentration of H2O2 for 2 h at 30°C. Serial dilutions were spotted onto YPD plates and
incubated for 36 to 48 h at 30°C. (B) Cells (W303 background) were treated as described for panel A. (C) cox11⌬ cells expressing either an empty
vector, COA2, or COX10 were grown to mid-exponential phase, incubated with (⫹) or without (⫺) the indicated concentrations of hydrogen
peroxide, and spotted onto YPD plates. (D) WT, shy1⌬, and cox11⌬ cells as well as shy1⌬ cox11⌬ cells expressing either COX11 or SHY1 were
treated as described for panel A.

leads to a marked enhancement in Cox1 synthesis, but the
newly synthesized Cox1 does not progress to assembled CcO
(8). Deletion of either COA1 or COX14 in coa2⌬ cells leads to
a pronounced increase in newly synthesized Cox1 in an in vivo
mitochondrial translation assay. The accumulated Cox1 must
be in an environment where it is protected from the protease
responsible for its rapid degradation in coa2⌬ cells. Cox14 and
Coa1 are essential to coordinate Mss51’s posttranslational
function, leading to cofactor insertion in Cox1 (29). Despite
the elevation in the level of newly synthesized Cox1, the deletion of COX14 or COA1 in coa2⌬ cells reverses the peroxide
sensitivity, suggesting that this expanded Cox1 is devoid of
heme a3. Therefore, disruption of COX14 or COA1 likely prevents newly synthesized Cox1 from joining the assembly chain
and acquiring the heme a3 center.
At what step in CcO assembly is Coa2 important? Two lines
of evidence suggest that Coa2 functions downstream of Coa1
and Mss51. First, Coa2 is a suppressor of the respiratory defect
of coa1⌬ cells. Second, the Coa1-Mss51-Cox14 A2 complex
persists in coa2⌬ cells. The attenuation of the A1 Mss51 complex in coa2⌬ cells may arise if this Mss51 complex contains
Cox1. This interpretation is consistent with the absence of this
complex in pet309⌬ cells and in WT cells treated with chloramphenicol. The presence of the A2 Mss51 complex in coa2⌬
cells but not in chloramphenicol-treated WT cells suggests that
either the limited amount of Cox1 present in coa2⌬ cells is

sufficient to stabilize this complex or this complex is indirectly
dependent on Cox1 translation. In any case, the presence of
the A2 Mss51 complex in coa2⌬ cells supports the assertion
that Cox1 is translated and that Coa2 functions downstream of
Mss51 in a posttranslational step.
Coa2 appears to have a role near the heme a3-related function of Shy1. The Shy1 protein complex observed by BNPAGE is destabilized and size shifted in coa2⌬ cells. Shy1
protein complexes of 250 to 400 kDa contain Cox1 (25), so part
of the destabilization of the Shy1 complexes observed in coa2⌬
cells may arise from attenuated Cox1 levels. However, the
interaction between Coa2 and Shy1 detected by co-IP suggests
a direct effect of Coa2 on Shy1. The Coa2-Shy1 complex does
not appear to be of sufficient stability for visualization by BNPAGE with tagged Coa2 cells. This may also account for the
low level of co-IP.
The absence of Coa2 does not preclude heme a3 insertion, as
coa2⌬ cells are peroxide sensitive and this sensitivity is reversed by the deletion of SHY1. The role of Shy1 in heme a3
insertion is corroborated by the observation that the peroxide
sensitivity of cox11⌬ cells is reversed with depletion of Shy1.
Thus, Shy1 appears to participate in heme a3 insertion in yeast
as well as in Rhodobacter (31). Heme a3 insertion is not strictly
dependent on Shy1, since shy1⌬ cells have residual CcO activity and the respiratory defect of the null cells is suppressed by
overexpression of either MSS51 or COA2. Although Shy1 ap-
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FIG. 9. Overexpression of Cox10 and Cox5a can partially rescue the respiratory deficiency of coa2⌬ cells. (A) coa2⌬ cells were transformed with
an empty vector, COA2, COX10, or MSS51, grown in SC-2% raffinose, and then serially diluted and spotted on YPLG or YPD. The plates were
incubated at 30°C for 2 days (YPD) or 4 days (YPLG). (B) In vivo labeling of mitochondrial translation products in coa2⌬ cells overexpressing
COX10. Cells were labeled for 8 and 20 min with [35S]Met at 30°C (P). After the 20-min pulse, excess unlabeled Met was added, and the cells were
chased for 100 min (C). The samples were run by 12% SDS-PAGE, and the gel was dried and exposed to autoradiographic film. (C) In vivo labeling
of mitochondrial translation products in cells lacking CcO subunits. Cells (BY4743 background) were labeled and analyzed as described for panel
B. (D) W303 coa2⌬ cells transformed with episomal vectors expressing COX5a or COX6 were grown in SC-2% raffinose, serially diluted, and
spotted on YPLG or YPD. The plates were incubated at 30°C and 37°C for 2 days (YPD) or 7 days (YPLG). (E) Immunoblot of trichloroacetic
acid extracts from W303, coa2⌬, and cox19⌬ cells containing a centromeric vector expressing a three-HA C-terminally tagged version of COX5a
under the control of its own promoter. Porin (Por1) is shown as a loading control.

pears to be important in the heme a3 insertion step, Shy1 stays
associated with CcO until the supercomplex stage (25). It remains unclear whether Shy1 has any function downstream of
the proposed heme a3 assembly step.
Proteolytic degradation of Cox1 may be a protective response to the assembly of the pro-oxidant heme a3-Cox1 intermediate. In the absence of heme a3 insertion, Cox1 assembly intermediates, e.g., in cox14⌬ cells, are not deleterious and
perhaps not a priority for the cell to remove proteolytically.
Cox1 degradation appears to be attenuated in coa2⌬ cells by
the overexpression of COX10 or COX5a/COX6. COX5a and
COX6 were recently shown to partially suppress the respiratory
defect of shy1⌬ cells (15). In this case, it was suggested that
Cox5a and Cox6 protect newly synthesized Cox1 from proteolytic degradation. It is possible that at least part of the decrease
in the amount of newly synthesized Cox1 observed in shy1⌬
cells actually results from rapid degradation of Cox1, not entirely from a translation block. This argument is supported by
the observations that a COX1(1-512)::ARG8 shy1⌬ strain has
no growth defect on medium lacking Arg (28) and that normal
levels of Arg8 are present in the COX1(1-512)::ARG8 strain in
the absence of SHY1 (28). Therefore, the same rapid Cox1
proteolysis may occur in shy1⌬ cells as well as in coa2⌬ cells,

suggesting that in the absence of these factors, Cox1 forms an
unstable conformer. Given the close packing of Cox5a against
Cox1, Cox5a may have a stabilizing effect on newly synthesized
Cox1.
An early step in Cox1 maturation is formation of the Cox1Cox5a-Cox6 subassembly complex (32, 37). Cox5a packs
against transmembrane helices 11 and 12 in Cox1 and, together
with Cox6, docks onto the matrix face of the Cox1 helical
barrel, stabilizing loops connecting the 12 membrane helices.
This complex accumulates in mammalian cells with mutations
in SURF1 (Shy1) (32, 37). This assembly intermediate likely
contains heme a, since mutant Cox10 or Cox15 fibroblast lines
fail to form this intermediate (1, 2). Heme a is axially coordinated by histidyl residues from Cox1 helices 2 and 10, and its
farnesyl tail packs between helices 1, 11, and 12 (34). Thus,
heme a insertion may assist in organizing the Cox1 helices
creating the Cox5a interface.
It is conceivable that heme a produced by Cox10/Cox15 and
inserted into newly synthesized Cox1 creates a Cox1 conformer
competent for Cox5a-Cox6 binding. The heme a3-CuB site may
be formed in a second step mediated by Shy1 and Cox11.
These two steps may occur concurrently rather than sequentially. In support of concurrent steps, a 300-kDa Cox1 assembly
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FIG. 10. Coa2 and Mss51 overexpression in cox5a⌬ cells results in increased levels of Cox1. (A) The COX1(1-512)::ARG8 strain lacking
COX5a, with or without episomal vectors expressing COA2 or MSS51, was grown in SC-2% glucose containing 1⫻ Arg (20 mg/liter), serially
diluted, and spotted on SC-2% glucose containing 1⫻ Arg (⫹Arg) or no Arg (⫺Arg). The plates were incubated at 30°C for 2 days. (B) W303
cox5a⌬ cells containing the same plasmids as those described for panel A were labeled for 8 and 20 min with [35S]Met at 30°C. The samples were
run by 12% SDS-PAGE, and the gel was dried and exposed to autoradiographic film. (C) The same cells as those in panel B were grown to
mid-exponential phase and incubated with (⫹) or without (⫺) the indicated concentration of H2O2 for 2 h at 30°C. Serial dilutions were spotted
onto YPD plates and incubated for 36 to 48 h at 30°C.

intermediate observed by BN-PAGE contains both Shy1 and
Cox5a, although distinct 250-kDa complexes exist with either
Shy1 or Cox5a (25). Coa2 may also have a chaperone activity
in promoting Cox5a/Cox6 association with Cox1. The inability
to efficiently form the Cox1-Cox5a-Cox6 intermediate in coa2⌬
cells could expose Cox1 to rapid proteolysis. Coa2 likely suppresses the shy1⌬ respiratory defect via a posttranslational
effect on Cox1. We did not detect any enhancement of the
suppression of shy1⌬ cells by Coa2 when Cox5a and Cox6 were
also overexpressed. Therefore, it is probable that Coa2 suppresses the respiratory defect of shy1⌬ cells by a similar mechanism to that for Cox5a and Cox6, which was proposed to be
due to increasing the stability of newly synthesized Cox1 (15).
Such a role of Coa2 would also explain the H2O2 sensitivity of
a cox5a⌬ strain overexpressing Coa2 and the enhanced H2O2
sensitivity of cox11⌬ cells with high levels of COA2.
Cells lacking Coa2 may stall CcO assembly due to additional
factors other than merely Cox1 instability. Details on addi-

tional contributions of Coa2 to CcO assembly will await future
studies on Coa2.
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